Results 201 to 210 of about 81,668 (249)
Femoral radiographic indices for pre-operative osteoporosis screening in postmenopausal female patients undergoing total hip arthroplasty for osteoarthritis. [PDF]
PLoS OneNishi M +6 more
europepmc +1 more source
GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression. [PDF]
J Orthop Surg ResWu K, Ren W, Xu B, Shen J, Xu K, Hu Y.
europepmc +1 more source
Associations between body composition and bone loss in early postmenopausal women. [PDF]
J Bone Miner ResGeraldi MV +5 more
europepmc +1 more source
Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Front Endocrinol (Lausanne)Chen L, Wang Q, Gu M.
europepmc +1 more source
Combined Nanoparticle-Based Delivery of Estrogens and Raloxifen in Postmenopausal Osteoporosis. [PDF]
Nanomaterials (Basel)Włodarczyk A, Dolibog P.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Clinics of North America, 1987
Osteoporosis is a major public health problem, particularly for the postmenopausal woman. With the withdrawal of estrogen at menopause, bone resorption begins to exceed formation in remodeling cycles and bone mass is inexorably lost. Clearly, preventing postmenopausal osteoporosis is the aim of management.
S J, Silverberg, R, Lindsay
+9 more sources
Osteoporosis is a major public health problem, particularly for the postmenopausal woman. With the withdrawal of estrogen at menopause, bone resorption begins to exceed formation in remodeling cycles and bone mass is inexorably lost. Clearly, preventing postmenopausal osteoporosis is the aim of management.
S J, Silverberg, R, Lindsay
+9 more sources
Current Opinion in Endocrinology, Diabetes & Obesity, 2013
The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with ...
Dima L, Diab, Nelson B, Watts
openaire +2 more sources
The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with ...
Dima L, Diab, Nelson B, Watts
openaire +2 more sources
Current Osteoporosis Reports, 2004
The postmenopausal state is the most common underlying cause for osteoporosis and most of our understanding of the condition relates to this group. Recent evidence has suggested that hormone therapy may no longer have the pre-eminent place it once held but the same studies have also confirmed its antifracture efficacy. However, an increasing variety of
openaire +4 more sources
The postmenopausal state is the most common underlying cause for osteoporosis and most of our understanding of the condition relates to this group. Recent evidence has suggested that hormone therapy may no longer have the pre-eminent place it once held but the same studies have also confirmed its antifracture efficacy. However, an increasing variety of
openaire +4 more sources